易方达中证万得生物科技指数(LOF)C(010572)财务指标
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 本期已实现收益 |
-1,819,837.35 |
-15,892,080.78 |
-5,453,089.29 |
-9,606,172.63 |
| 本期利润 |
-10,807,663.80 |
9,137,775.37 |
9,664,262.62 |
-21,138,781.19 |
| 加权平均基金份额本期利润 |
-0.04 |
0.04 |
0.05 |
-0.13 |
| 本期加权平均净值利润率(%) |
-8.40 |
7.73 |
9.96 |
-25.85 |
| 本期基金份额净值增长率(%) |
-7.22 |
13.51 |
9.77 |
-20.91 |
| 期末可供分配利润 |
-119,794,135.10 |
-95,196,197.08 |
-75,328,246.19 |
-70,184,338.21 |
| 期末可供分配基金份额利润 |
-0.44 |
-0.44 |
-0.39 |
-0.36 |
| 期末基金资产净值 |
135,743,878.06 |
118,455,956.08 |
101,117,184.85 |
92,600,580.81 |
| 期末基金份额净值 |
0.50 |
0.54 |
0.52 |
0.48 |
| 基金份额累计净值增长率(%) |
-45.20 |
-40.94 |
-42.88 |
-47.97 |